Francesca DeMartino Named Sr VP of BD Investor Relations

Francesca DeMartino has been named senior vice president of BD investor relations for the company, effective Nov. 29.

In this role, DeMartino will lead all aspects of communicating progress of the BD2025 strategy to investors and the financial community, including the company’s initiatives that drive shareholder value. DeMartino will report to Chris DelOrefice, executive vice president and chief financial officer for BD. She succeeds Kristen Stewart who has been named senior vice president of enterprise strategy and insights for BD.

“Francesca is an accomplished leader with a long track record of success in investor relations, including extensive experience in the medical technology industry,” said DelOrefice. “She will lead BD’s efforts to highlight key milestones as we deliver on our strategy to drive growth through innovation.”

DeMartino has more than 20 years of combined experience in investor relations, communications and corporate finance, with her most recent position as vice president of investor relations at Medtronic. During her tenure, the function received IR Magazine awards for Best Overall Investor Relations and Best Investor Relations in Health Care. She had previously served as vice president of corporate communications and vice president of global communications for the Diabetes Group. Prior to joining Medtronic, DeMartino held positions of increasing responsibility at Johnson & Johnson, OMRIX Biopharmaceuticals, Macrocure Ltd, GCI Group and The Ruth Group. She began her career at Deutsche Bank AG as a financial analyst in the Health Care Investment Banking Group.

DeMartino holds a Bachelor of Arts in international and area studies from the University of California, Berkeley and a minor in business administration from the Walter A. Haas School of Business.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.
Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
Christopher Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy